top of page
BPIQ Blog
Nov 23, 20211 min read
Biopharma Daily Stock Updates - 11/23/21
$XBI $119.38 +0.1% Covid Updates $VALN +3.5% Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19...
Nov 22, 20213 min read
Biopharma Daily Stock Updates - 11/22/21
$XBI $119.28 -2.17% Covid Updates $BNTX +11.0% $PFE +0.8% Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support...
Nov 19, 20212 min read
Biopharma Daily Stock Updates - 11/19/21
$XBI $121.92 -0.25% Covid Updates $MRNA U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with...
Nov 18, 20212 min read
Biopharma Daily Stock Updates - 11/18/21
$XBI $122.22 -0.58% Pipeline Updates $ASND -4.1% Ascendis Pharma A/S Announces Top-Line Results from Week 84 of Its Phase 2 PaTH Forward...
Nov 17, 20211 min read
Biopharma Daily Stock Updates - 11/17/21
$XBI $122.93 -1.27% Covid Updates $NVAX +7.9% Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for...
Nov 16, 20211 min read
Biopharma Daily Stock Updates - 11/16/21
$XBI $124.51 +0.50% Pipeline Updates $INO -0.3% INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster...
Nov 15, 20213 min read
Biopharma Daily Stock Updates - 11/15/21
$XBI $123.89 -2.1% Covid Updates $MRNA +1.7% Health Canada Authorizes Booster Dose of Moderna’s COVID-19 Vaccine in Individuals 18...
Nov 12, 20212 min read
Biopharma Daily Stock Updates - 11/12/21
$XBI $126.54 +0.18% Covid Updates $VIR Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of...
Nov 11, 20211 min read
Biopharma Daily Stock Updates - 11/11/21
$XBI $126.31 +0.1% Pipeline Updates $CRTX -7.4% Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants With Alzheimer’s...
Nov 10, 20212 min read
Biopharma Daily Stock Updates - 11/10/21
$XBI $126.19 -1.9% Covid Updates $VALN +24.3% Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60...
Nov 9, 20213 min read
Biopharma Daily Stock Updates - 11/09/21
$XBI $128.63 -1.44% Covid Updates $BNTX -6.7% & $PFE -2.2% Pfizer and BioNTech Submit Request to Amend U.S. FDA Emergency Use...
Nov 8, 20212 min read
Biopharma Daily Stock Updates - 11/08/21
$XBI $130.51 -0.61% Covid Updates $COCP +3.6% Cocrystal Pharma’s SARS-CoV-2 Main Protease Inhibitors Demonstrate Pan-viral Activity...
Nov 5, 20212 min read
Biopharma Daily Stock Updates - 11/05/21
$XBI $131.32 -1.42% Covid Updates $OCGN Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for...
Nov 4, 20214 min read
Biopharma Daily Stock Updates - 11/04/21
$XBI $133.21 -0.70% Covid Updates $VERA -6.6% US Food and Drug Administration Declines Emergency Use Authorization for ZYESAMI®...
Nov 3, 20212 min read
Biopharma Daily Stock Updates - 11/03/21
$XBI $134.15 +2.2% Covid Updates $SRNE +4.0% Sorrento Receives Brazilian Health Regulatory Agency (ANVISA) Approval for COVISTIXâ„¢...
Nov 2, 20212 min read
Biopharma Daily Stock Updates - 11/02/21
$XBI $131.26 +1.29% Covid Updates $ABCL +4.1% Lilly to Supply 614,000 Additional Doses of AbCellera-Discovered Bamlanivimab Together with...
Nov 1, 20213 min read
Biopharma Daily Stock Updates - 11/01/21
$XBI $129.59 +3.83% Covid Updates $COCP +5.9% Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for...
Oct 29, 20211 min read
Biopharma Daily Stock Updates - 10/29/21
$XBI $124.81 -1% Covid Updates $PFE & $BNTX Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine...
Oct 28, 20212 min read
BPIQ Pro Daily Stock Updates - 10/28/21
$XBI $126.17 +3.5% Pipeline Updates $GILD Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® (sacituzumab...
Oct 27, 20212 min read
Biopharma Daily Stock Updates - 10/27/21
$XBI $122.22 -1.44% Covid Updates $SRNE -0.6% Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page